- Open Access
Combined genetic effects of EGLN1 and VWF modulate thrombotic outcome in hypoxia revealed by Ayurgenomics approach
- Shilpi Aggarwal†1,
- Atish Gheware†2, 4,
- Anurag Agrawal1, 4,
- Saurabh Ghosh3,
- Indian Genome Variation Consortium1,
- Bhavana Prasher2, 4Email author and
- Mitali Mukerji1, 2, 4Email author
© Aggarwal et al. 2015
- Received: 15 May 2015
- Accepted: 18 May 2015
- Published: 6 June 2015
Extreme constitution “Prakriti” types of Ayurveda exhibit systemic physiological attributes. Our earlier genetic study has revealed differences in EGLN1, key modulator of hypoxia axis between Prakriti types. This was associated with differences in high altitude adaptation and susceptibility to high altitude pulmonary edema (HAPE). In this study we investigate other molecular differences that contribute to systemic attributes of Prakriti that would be relevant in predictive marker discovery.
Genotyping of 96 individuals of the earlier cohort was carried out in a panel of 2,800 common genic SNPs represented in Indian Genomic Variation Consortium (IGVC) panel from 24 diverse populations. Frequency distribution patterns of Prakriti differentiating variations (FDR correction P < 0.05) was studied in IGVC and 55 global populations (HGDP–CEPH) panels. Genotypic interactions between VWF, identified from the present analysis, and EGLN1 was analyzed using multinomial logistic regression in Prakriti and Indian populations from contrasting altitudes. Spearman’s Rank correlation was used to study this genotypic interaction with respect to altitude in HGDP–CEPH panel. Validation of functional link between EGLN1 and VWF was carried out in a mouse model using chemical inhibition and siRNA studies.
Significant differences in allele frequencies were observed in seven genes (SPTA1, VWF, OLR1, UCP2, OR6K3, LEPR, and OR10Z1) after FDR correction (P < 0.05). A non synonymous variation (C/T, rs1063856) associated with thrombosis/bleeding susceptibility respectively, differed significantly between Kapha (C-allele) and Pitta (T-allele) constitution types. A combination of derived EGLN1 allele (HAPE associated) and ancestral VWF allele (thrombosis associated) was significantly high in Kapha group compared to Pitta (p < 10–5). The combination of risk-associated Kapha alleles was nearly absent in natives of high altitude. Inhibition of EGLN1 using (DHB) and an EGLN1 specific siRNA in a mouse model lead to a marked increase in vWF levels as well as pro-thrombotic phenotype viz. reduced bleeding time and enhanced platelet count and activation.
We demonstrate for the first time a genetic link between EGLN1 and VWF in a constitution specific manner which could modulate thrombosis/bleeding susceptibility and outcomes of hypoxia. Integration of Prakriti in population stratification may help assemble common variations in key physiological axes that confers differences in disease occurrence and patho-phenotypic outcomes.
- High altitude
- Deep vein thrombosis
- Predictive medicine
There has been a deluge of variations from complete human genome sequencing projects [1, 2]. Majority of the common variations are shared across world populations and contribute to 98% inter-individual variance within populations [3–6]. Identification of meaningful variations that connect to human phenotypes and explain inter-individual variability in adaptation and susceptibility differences is the current challenge [7–10]. Integrative analysis of global variation data with environmental, geographical, dietary and cultural practices across diverse populations have helped identify common variations linked to local adaptations in different eco-clines like latitude, climate as well as mode of subsistence [11–16]. These variations correlate with phenotypic, physiological and metabolic traits and overlap with signals from GWAS studies [8, 14–17]. Besides, system biology and data intensive approaches like PheWAS are being evolved to identify phenotypic links through shared genotypes [18–21]. There is a need to evolve methods to stratify individuals even within a genetically homogeneous population on the basis of their shared physiological attributes that could give rise to different health trajectories.
India has a 3,500 year old system of medicine, Ayurveda which has at its basic tenet a predictive and participatory approach for preventive and personalized medicine [10, 22]. In this approach healthy individuals are phenotypically stratified into seven different constitution types called Prakriti which also determines an individual’s differential susceptibility to disease, response to diet, environment and therapy [10, 22]. A unique aspect of this approach is that different phenotypic attributes of an individual, such as morphological features, skin type, physiology, metabolism, mental aptitudes, sensory perception etc. are comprehensively assessed for defining each constitution type . Inter-individual variability in underlying physiological parameters related to different body tissues (qualitative and quantitative) have also been described. For instance, blood characteristics including color and viscosity are described to vary among different Prakriti as well as in response to geo-climatic conditions including seasonal variations. This also sets a prelude for differential susceptibility to blood related disorders like bleeding, hyper-coagulability or thrombosis. This forms the basis for personalized health maintenance and preventive medicine through diet and life style modifications (Additional file 1).
Amongst the seven types, Vata (V), Pitta (P) and Kapha (K) are the three phenotypic extremes that are readily distinguishable [22–25]. Many of the phenotypic features that distinguish the predominant Prakriti types overlap with attributes described for human adaptations. We have earlier provided molecular and genomic evidence of differences between contrasting constitution types from a genetically homogeneous background . Common variations from a subset of differentially expressed genes also partitioned differently between the phenotypically stratified Prakriti groups . Once these groups were pooled, the variations assumed an average frequency similar to the genetic background of the population. Further analysis of EGLN1 variation helped identify, hypoxia as one of the axis and capture genetic marker attributable to specific constitutions for high altitude hypoxic adaptation .
We hypothesize that integration of the comprehensive phenotyping method of Ayurveda with genomics might provide scaffolds to connect major axes of variation to an individual’s phenome. In this study we carried out our analysis on a set of ~2,800 polymorphic genic SNPs, represented in the Indian Genome Variation Consortium panel [27, 28]. We identify common variations that differ between healthy individuals of contrasting Prakriti types in genes that govern blood cell traits, hemostasis, metabolism, lipid homeostasis, etc. We could thread hypoxia (EGLN1) to hemostasis (VWF) and red blood cell traits (SPTA1) in a constitution specific manner. We provide genetic and experimental evidence of how in the background of earlier reported EGLN1 variations that link to differences in hypoxia responsiveness, vWF variations/levels could modulate risk for thrombosis. We thus propose that an Ayurgenomics approach could enable assembly of common variations linked to different physiological axes which could assume importance in adaptability to different geo-climatic conditions and susceptibility to diseases.
The study was carried out on the same samples [22, 26] that have been used in our earlier studies. Sample collection was carried out following approval of Institutional Bioethics Committee (IBC). Briefly the samples comprised of (1) 96 individuals comprising of extreme constitution types Vata (n = 39) Pitta (n = 29) and Kapha (n = 28) identified from an initial phenotyping of 850 volunteers on the basis of Ayurveda methods and recruited in our earlier study. (2) 552 samples from 24 diverse Indian populations from the existing panel of IGVC [26, 28]. These include 92 heterogeneous phenotype controls (IE-pool) from Indo-European North Indian large populations (size >10 million).
Genetic study and analysis
We carried out our analysis on a panel of 2,800 SNPs from 776 genes on whom the genotype information was available from the IGVC panel Phase II (http://igvbrowser.igib.res.in, ). These SNPs were genotyped in VPK samples using Illumina Bead Array platform. The SNPs tagged a set of representative genes/genic regions that have been implicated in a number of monogenic and complex diseases. These genes mapped to diverse biological processes and molecular functions. Genotype data on EGLN1 and VWF from 55 populations were retrieved from the data of Stanford Human Genome Diversity Panel (HGDP) SNP Genotyping Data on 650 K Illumina arrays available on HGDP selection browser (http://hgdp.uchicago.edu/, ). The altitude of each of the populations in the HGDP panel was retrieved from the earlier study .
Fisher’s exact test  was carried out for testing genotypic and allelic associations between the Prakriti types as well as between Prakriti and IE-pool background. Correction for multiple testing was done using the FDR method.
We compared the frequency of combined genotypes of EGLN1 and VWF between the Prakriti types and in high altitude natives and a related population from sea level (Additional files 2, 3). Combined genetic analysis was carried out considering EGLN1 allele associated with high altitude adaptation and VWF allele associated with non thrombotic phenotype as protective alleles. We evolved a scoring mechanism wherein the total count of the protective alleles in EGLN1 and the VWF genotypes in an individual was calculated. Thus, a score of “0” corresponds to individuals homozygosity for the risk allele ‘C’ at both rs480902/rs1063856 (that is, the genotype CC/CC) and a score of 4 where all the alleles were protective (that is, the genotype TT/TT). All the nine genotypes were considered and converted to these scores. Multinomial logistic regression was performed to associate these scores and the Prakriti types (K/V/P). We used binary logistic regression to test for differences in the distribution of scores between (1) individuals residing at high altitude and those residing at sea-level and (2) individuals residing at high altitudes and the Prakriti group “P”. In order to study the possible relationship between the scores of individuals belonging to the different HGDP populations and the altitudes corresponding to these populations, we computed the Spearman’s rank correlation between the mean scores of each population and the altitudes (Additional file 4).
Animals and experimental protocol
Male BALB/c mice (8–10 week old with an average weight of 25 grams; obtained from CSIR-Central Drug Research Institute, Lucknow, India) were acclimatized for 1 week before starting the experiments. All animals were maintained as per the guidelines of the Committee for the Purpose of Control and Supervision of Experiments on Animals (CPCSEA), and the protocols were approved by the Institutional Animal Ethics Committee of CSIR-IGIB.
Ethyl-3, 4-dihydroxy benzoic acid (DHB) treatment
Mice were divided into three groups (n = 5–6), according to the treatment: Vehicle (10% ethanol), D5 (DHB 5 mg/kg), D10 (DHB 10 mg/kg). DHB (TCI AMERICA, Portland, OR, USA) and 10% ethanol was administered via Intraperitoneal (I.P.) injection at 100 µl volume for 7 consecutive days.
Mice were divided into three groups (n = 5–6), according to the treatment: Naive (untreated mice), Scram siRNA (scrambled siRNA treated mice) and PHD2 siRNA (PHD2 siRNA treated mice). For assessing the systemic effect we used the intranasal route for siRNA delivery as described previously . Briefly, 90 µg of PHD2 (Dharmacon, Lafayette, CO) or scrambled siRNA (Dharmacon, Lafayette, CO) dissolved in 30 ml of ultrapure DNase and RNAse free water was administered intranasally to isoflurane-anesthetized mice. SiRNA was given on day 1, 3 and 5. The animals were sacrificed on day 6 from the start of the experiment.
Tail bleeding assay (bleeding time assay)
On the final day of protocol (DHB or siRNA experiment), mice were anaesthetized in prone position. A 10 mm segment of the tail from the distal end was amputated with sharp scalpel. The tail was then immediately immersed in 50 ml of PBS (pre-warmed to 37°C in a water bath) contained in a Falcon tube. The position of tail was kept vertical with tip positioned about 2 cm below the PBS meniscus. The bleeding time was then determined by monitoring the duration of animal tail bleeding until it ceased, using a stop clock.
Blood was obtained by cardiac puncture and collected in EDTA coated MiniCollect tubes (Greiner Bio-One Gmbh, kremsmünster, Austria). Plasma was isolated by centrifugation of blood at 1,000g for 15 min at 4°C and kept in −80°C for further use. HIF1α and vWF levels were measured in plasma sample by using ELISA kit (USCNk, Wuhan, China) as per the manufacturer’s protocol. The whole blood was used to measure the total count of platelets and its distribution width by using automated hematology analyzer (Nihon kohden, Japan). Assessment of active and total Platelet count was carried out through flow cytometry using FACSCalibur (BD Biosciences, USA). Briefly, 100 μl of blood was diluted in 400 μl of TBS. This diluted whole blood (1:4) was then incubated with APC conjugated anti-CD62P (eBioscience Inc, San Diego, CA, USA) and FITC conjugated anti-CD41 (eBioscience Inc, San Diego, CA, USA) for 15 min. Matched fluorescein conjugated isotype control antibodies were used simultaneously for staining, to set the threshold and exclude nonspecific binding. Activity was compared using CellQuest Pro software (BD Biosciences, USA).
Statistical significance was determined by the Student’s t test. Non parametric statistical test Mann–Whitney rank sum test or Wilcoxon matched pair test was used wherever the data does not follow the Gaussian distribution. Analysis was done using GraphPad Prism software 5.0.
Common variations partition differently amongst healthy individuals of extreme constitution types
SNPs that show significant differences between the Prakriti groups after FDR correction for multiple testing set at a threshold of significance of p < 0.05
Allele frequency 1
Allele frequency 2
Allele frequency (1 vs. 2)
Interestingly we reported a similar observation with respect to a genetic variation in EGLN1 linked to its expression in our earlier study. We observed a variation linked to lower expression of EGLN1 in Pitta Prakriti as well as natives of high altitude both in Indian and global populations whereas the other allele significantly overrepresented in Kapha and sea level sojourners who developed high altitude pulmonary edema . However in case of EGLN1 it was ancestral allele that was fixed in natives of high altitude whereas in case of VWF we observed the derived allele linked to low levels of vWF to be nearly fixed in high landers. We hypothesize that low levels of EGLN1 due to environmental hypoxia or a genetic variation could result in elevated vWF as a consequence of angiogenesis and confer thrombosis risk. Hence we anticipate, fixation of a non-thrombotic/derived allele in the background of protective EGLN1 genotype could give an advantage in high altitude condition as well as in conditions where HIF related pathways are expected to be elevated.
We studied the distribution of common variations, represented in the IGVC panel, in the healthy individuals of extreme Ayurvedic constitution types. These predominant constitutions types belong to one of the genetically homogeneous clusters identified in the IGVC project that comprises Indo-European population from North India [27, 28]. We observed significant differences in SNP allele frequency in seven genes (SPTA1, VWF, OLR1, UCP2, OR6K3, LEPR, and OR10Z1) between the constitution types. These genes are important players in governing major axes like blood cell traits, hemostasis, metabolism and lipid homeostasis in healthy individuals and have also been associated with risk for bleeding disorders, CVD, stroke, obesity, atherosclerosis [34–42]. These not only differ between constitution types but also correlate with phenotypes that differentiate the Prakriti types. Prakriti as mentioned above not only exhibit phenotypic differences but also renders differential responsiveness to environmental conditions as well as susceptibility to diseases. Extreme Prakriti types in any population are at the end of phenotypic spectrum and have contrasting responsiveness to intrinsic and extrinsic stimuli. Majority of the variations that differ between the extreme Prakriti types are shared across diverse populations and their frequencies can vary on account of selection pressures such as climatic conditions, mode of subsistence, pathogen pressure and cultural practices even in genetically related populations [12–14], (Additional file 6). Many of these also overlap with signals associated with different diseases and phenotypic traits in GWAS studies [35–42]. Thus the same variation associated with a constitution type could assume importance in adaptation or disease susceptibility/protection based on the context.
The ancestral ‘C’ allele of VWF rs1063856 has been associated with elevated plasma von Willebrand factor levels and the risk of incident venous thrombosis [43, 44]. Besides mutation in VWF gene leading to its reduced expression has also been linked to bleeding susceptibility .
In an earlier study, we have reported expression and allelic frequency differences in an oxygen sensor EGLN1 between Pitta and Kapha Prakriti types . The genotype linked to higher expression of EGLN1 was observed in Kapha and HAPE. EGLN1 inactivates HIF-1a in high oxygen conditions. Under hypoxic conditions EGLN1 is inactive leading to elevated HIF-1a levels, which switches on a large number of genes including those linked to angiogenesis [45, 46]. The same variation in EGLN1 gene has been associated with high altitude adaptation in multiple populations of the world [47–49]. Levels of vWF have been shown to be elevated in cellular hypoxic conditions [50–53].
It is conceivable that in the background of an ancestral favourable allele, there might be selection for newer alleles that are physiologically advantageous. For instance, in the presence of an ancestral allele of EGLN1 that favours high altitude adaptation, elevated risk for thrombosis can arise as a consequence of angiogenesis due to high levels of vWF. We could functionally validate the observed link obtained between EGLN1 and VWF genotypes through chemical and siRNA mediated inhibition of PHD2 in a mouse model (Figures 4, 5). In the presence of hypoxia as a consequence of PHD2 inhibition not only VWF but markers that are associated with increased risk for thrombosis were observed to be elevated. Our results support the previous findings [54–56]. Thus increasing concentration of the chemical inhibitor DHB which inhibits the activity of PHD2 leading to enhanced hypoxic response results in a prothrombotic phenotype viz increased platelet count and activation and reduced bleeding time. This is in line with previous work showing that hypoxia elevates the VWF expression [50–53]. Thus, both chemical and siRNA mediated inhibition of PHD2 leads to a pro-thrombotic phenotype in mice corroborating with our genetic finding.
Therefore, presence of a derived (non-thrombotic) allele of VWF in the background of elevated HIF could confer protection from thrombosis in Pitta Prakriti types as well as in high altitude natives.
The ancestral allele linked to higher level of VWF needed for coagulation might be important in protection from blood loss due to various reasons. However, this might not be favourable in high altitude where already a constitutive state of hypoxia can promote thrombosis. This could be the reason for near fixation of the derived non-thrombotic state of VWF in high altitude population of India as well as in the other high altitude regions of the world. Incidentally the high altitude region in India where TB-N-IP1 resides is also classified as a dry desert. Prolonged low oxygen conditions and dryness are known to precipitate deep vein thrombosis through platelet aggregation for instance in long distance fliers. Our observation might also assume importance in identifying individuals who might be differentially susceptible to deep vein thrombosis.
In Ayurveda, seven different constitutions types with varying proportions of Vata, Pitta and Kapha are described to be present in all populations. These proportions are determined by ethnicity, heritability, geo-climatic adaptation, time and season which also govern the relative phenotypic optimum of the population. Prakriti assessment is carried out keeping these aspects in context for an individual. Prakriti integrates underlying physiological variability, adaptation to different climatic conditions as well as susceptibility to diseases. An environment such as high altitude which is described as Kapha-Vata promoting can lead to elevated Pitta component as a part of adaptation. However, amongst the sojourners from sea level who are not naturally adapted, individuals who have elevated Pitta levels might be more protected from high altitude sickness. This might explain the sharing of genotypes between high altitude natives and Pitta where adaptation might be a cause in the earlier one and in the later it can confer adaptability to high altitude environment. This observation lends credence to the Ayurveda’s personalized recommendation of diet and life style based on an individual’s constitution, habitat, seasons etc.
In this study, we demonstrate how stratification of normal healthy individuals can help uncover a novel and non-intuitive genetic link between hypoxia and hemostasis axes that is important both in adaptation and disease susceptibility. Complementation of Ayurveda based phenotypic classification of healthy individuals with population, environmental and geographical genomics approaches might not only allow us to partition common variations among healthy individuals but also help connect key physiological axes that confers differences in disease occurrence and patho-phenotypic outcomes. Given that Prakriti assessment is important in personalized recommendations for health and disease management, this could be important for translational medicine.
MM and BP conceived the project and designed the study. SA carried out the genetic variation data analysis. SG assisted in the statistical analysis. AA designed the mouse experiments and AG conducted the mouse study. All authors participated in analysis. MM and BP wrote the paper. All authors read and approved the final manuscript.
Financial support to MM, BP and AG from CSIR-TRISUTRA (MLP901), SA (CSIR-SRF) and CSIR-IGIB for infrastructure support is duly acknowledged. IT support from Pradeep Tiwari and Uma Anwardekar is acknowledged. We acknowledge V.P. Singh for mouse facility and Puneet Gupta and Bijay Pattnaik for their technical help in mice experiment and INMAS-Defence Research & Development Organization, Delhi for providing facility of platelet hematology analysis are also acknowledged.
Compliance with ethical guidelines
Competing interests The authors declare that they have no competing interests.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
- The International HapMap Project (2003) Nature 426:789–796View ArticleGoogle Scholar
- Abecasis GR, Auton A, Brooks LD, DePristo MA, Durbin RM, Handsaker RE et al (2012) An integrated map of genetic variation from 1,092 human genomes. Nature 491:56–65PubMedView ArticleGoogle Scholar
- Rosenberg NA, Pritchard JK, Weber JL, Cann HM, Kidd KK, Zhivotovsky LA et al (2002) Genetic structure of human populations. Science 298:2381–2385PubMedView ArticleGoogle Scholar
- Barbujani G, Magagni A, Minch E, Cavalli-Sforza LL (1997) An apportionment of human DNA diversity. Proc Natl Acad Sci USA 94:4516–4519PubMed CentralPubMedView ArticleGoogle Scholar
- Witherspoon DJ, Wooding S, Rogers AR, Marchani EE, Watkins WS, Batzer MA et al (2007) Genetic similarities within and between human populations. Genetics 176:351–359PubMed CentralPubMedView ArticleGoogle Scholar
- Gibson G (2011) Rare and common variants: twenty arguments. Nat Rev Genet 13:135–145PubMed CentralView ArticleGoogle Scholar
- Olson MV (2012) Human genetic individuality. Annu Rev Genomics Hum Genet 13:1–27PubMedView ArticleGoogle Scholar
- Frazer KA, Murray SS, Schork NJ, Topol EJ (2009) Human genetic variation and its contribution to complex traits. Nat Rev Genet 10:241–251PubMedView ArticleGoogle Scholar
- Venter JC (2010) Multiple personal genomes await. Nature 464:676–677PubMedView ArticleGoogle Scholar
- Sethi TP, Prasher B, Mukerji M (2011) Ayurgenomics: a new way of threading molecular variability for stratified medicine. ACS Chem Biol 6:875–880PubMedView ArticleGoogle Scholar
- Fumagalli M, Sironi M, Pozzoli U, Ferrer-Admetlla A, Pattini L, Nielsen R (2011) Signatures of environmental genetic adaptation pinpoint pathogens as the main selective pressure through human evolution. PLoS Genet 7:e1002355PubMed CentralPubMedView ArticleGoogle Scholar
- Hancock AM, Alkorta-Aranburu G, Witonsky DB, Di Rienzo A (2010) Adaptations to new environments in humans: the role of subtle allele frequency shifts. Philos Trans R Soc Lond B Biol Sci 365:2459–2468PubMed CentralPubMedView ArticleGoogle Scholar
- Hancock AM, Witonsky DB, Ehler E, Alkorta-Aranburu G, Beall C, Gebremedhin A et al (2010) Colloquium paper: human adaptations to diet, subsistence, and ecoregion are due to subtle shifts in allele frequency. Proc Natl Acad Sci USA 107(Suppl 2):8924–8930PubMed CentralPubMedView ArticleGoogle Scholar
- Hancock AM, Witonsky DB, Alkorta-Aranburu G, Beall CM, Gebremedhin A, Sukernik R et al (2011) Adaptations to climate-mediated selective pressures in humans. PLoS Genet 7:e1001375PubMed CentralPubMedView ArticleGoogle Scholar
- Scheinfeldt LB, Tishkoff SA (2013) Recent human adaptation: genomic approaches, interpretation and insights. Nat Rev Genet 14:692–702PubMedView ArticleGoogle Scholar
- Nath AP, Arafat D, Gibson G (2012) Using blood informative transcripts in geographical genomics: impact of lifestyle on gene expression in fijians. Front Genet 3:243PubMed CentralPubMedView ArticleGoogle Scholar
- Manolio TA, Collins FS (2009) The HapMap and genome-wide association studies in diagnosis and therapy. Annu Rev Med 60:443–456PubMed CentralPubMedView ArticleGoogle Scholar
- Denny JC, Ritchie MD, Basford MA, Pulley JM, Bastarache L, Brown-Gentry K et al (2010) PheWAS: demonstrating the feasibility of a phenome-wide scan to discover gene-disease associations. Bioinformatics 26:1205–1210PubMed CentralPubMedView ArticleGoogle Scholar
- Pendergrass SA, Brown-Gentry K, Dudek SM, Torstenson ES, Ambite JL, Avery CL et al (2011) The use of phenome-wide association studies (PheWAS) for exploration of novel genotype-phenotype relationships and pleiotropy discovery. Genet Epidemiol 35:410–422PubMed CentralPubMedView ArticleGoogle Scholar
- Pendergrass SA, Brown-Gentry K, Dudek S, Frase A, Torstenson ES, Goodloe R et al (2013) Phenome-wide association study (PheWAS) for detection of pleiotropy within the Population Architecture using Genomics and Epidemiology (PAGE) Network. PLoS Genet 9:e1003087PubMed CentralPubMedView ArticleGoogle Scholar
- Ye Z, Mayer J, Ivacic L, Zhou Z, He M, Schrodi SJ et al (2015) Phenome-wide association studies (PheWASs) for functional variants. Eur J Hum Genet 23(4):523–529PubMedView ArticleGoogle Scholar
- Prasher B, Negi S, Aggarwal S, Mandal AK, Sethi TP, Deshmukh SR et al (2008) Whole genome expression and biochemical correlates of extreme constitutional types defined in Ayurveda. J Transl Med 6:48PubMed CentralPubMedView ArticleGoogle Scholar
- Sharma PV (2000) Caraka Samhita (Text with English Translation), vol 1. Chaukhamba OrientaliaGoogle Scholar
- Sharma PV (2000) Susruta Samhita (English translation of text and Dalhana’s commentary), vol 1 and 2. Chaukhamba VisvabharatiGoogle Scholar
- Valiathan M (2003) The Legacy of Caraka. Orient LongmanGoogle Scholar
- Aggarwal S, Negi S, Jha P, Singh PK, Stobdan T, Pasha MA et al (2010) EGLN1 involvement in high-altitude adaptation revealed through genetic analysis of extreme constitution types defined in Ayurveda. Proc Natl Acad Sci USA 107:18961–18966PubMed CentralPubMedView ArticleGoogle Scholar
- Indian Genome Variation Consortium (2005) The Indian Genome Variation database (IGVdb): a project overview. Hum Genet 118:1–11View ArticleGoogle Scholar
- Indian Genome Variation Consortium (2008) Genetic landscape of the people of India: a canvas for disease gene exploration. J Genet 87:3–20View ArticleGoogle Scholar
- Indian Genome Database (IGVDb). http://igvbrowser.igib.res.in. Accessed 01 Mar 2015
- Human genome Diversity Panel (HGDP). http://hgdp.uchicago.edu/. Accessed 01 Mar 2015
- Ahmad T, Kumar M, Mabalirajan U, Pattnaik B, Aggarwal S, Singh R et al (2012) Hypoxia response in asthma: differential modulation on inflammation and epithelial injury. Am J Respir Cell Mol Biol 47:1–10PubMedView ArticleGoogle Scholar
- Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D et al (2007) PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81:559–575PubMed CentralPubMedView ArticleGoogle Scholar
- Denis CV, Lenting PJ (2012) von Willebrand factor: at the crossroads of bleeding and thrombosis. Int J Hematol 95:353–361PubMed CentralPubMedView ArticleGoogle Scholar
- Ganesh SK, Zakai NA, van Rooij FJ, Soranzo N, Smith AV, Nalls MA et al (2009) Multiple loci influence erythrocyte phenotypes in the CHARGE Consortium. Nat Genet 41:1191–1198PubMed CentralPubMedView ArticleGoogle Scholar
- Khaidakov M, Mitra S, Kang BY, Wang X, Kadlubar S, Novelli G et al (2011) Oxidized LDL receptor 1 (OLR1) as a possible link between obesity, dyslipidemia and cancer. PLoS One 6:e20277PubMed CentralPubMedView ArticleGoogle Scholar
- Predazzi IM, Rokas A, Deinard A, Schnetz-Boutaud N, Williams ND, Bush WS et al (2013) Putting pleiotropy and selection into context defines a new paradigm for interpreting genetic data. Circ Cardiovasc Genet 6:299–307PubMed CentralPubMedView ArticleGoogle Scholar
- Ulrich-Merzenich G, Zeitler H (2013) The lectin-like oxidized low-density lipoprotein receptor-1 as therapeutic target for atherosclerosis, inflammatory conditions and longevity. Expert Opin Ther Targets 17:905–919PubMedView ArticleGoogle Scholar
- Taye A, El-Sheikh AA (2013) Lectin-like oxidized low-density lipoprotein receptor 1 pathways. Eur J Clin Invest 43:740–745PubMedView ArticleGoogle Scholar
- Oktavianthi S, Trimarsanto H, Febinia CA, Suastika K, Saraswati MR, Dwipayana P et al (2012) Uncoupling protein 2 gene polymorphisms are associated with obesity. Cardiovasc Diabetol 11:41PubMed CentralPubMedView ArticleGoogle Scholar
- Yu X, Wieczorek S, Franke A, Yin H, Pierer M, Sina C et al (2009) Association of UCP2 -866 G/A polymorphism with chronic inflammatory diseases. Genes Immun 10:601–605PubMedView ArticleGoogle Scholar
- Villanueva EC, Myers MG Jr (2008) Leptin receptor signaling and the regulation of mammalian physiology. Int J Obes (Lond) 32(Suppl 7):S8–S12View ArticleGoogle Scholar
- Dutta D, Ghosh S, Pandit K, Mukhopadhyay P, Chowdhury S (2012) Leptin and cancer: pathogenesis and modulation. Indian J Endocrinol Metab 16:S596–S600PubMed CentralPubMedView ArticleGoogle Scholar
- Shahbazi S, Alavi S, Mahdian R (2012) Classification of exon 18 linked variants of VWF gene in von Willebrand disease. Int J Mol Epidemiol Genet 3:77–83PubMed CentralPubMedGoogle Scholar
- Smith NL, Rice KM, Bovill EG, Cushman M, Bis JC, McKnight B et al (2011) Genetic variation associated with plasma von Willebrand factor levels and the risk of incident venous thrombosis. Blood 117:6007–6011PubMed CentralPubMedView ArticleGoogle Scholar
- Smith TG, Robbins PA, Ratcliffe PJ (2008) The human side of hypoxia-inducible factor. Br J Haematol 141:325–334PubMed CentralPubMedView ArticleGoogle Scholar
- Semenza GL (2009) Regulation of oxygen homeostasis by hypoxia-inducible factor 1. Physiology (Bethesda) 24:97–106View ArticleGoogle Scholar
- Simonson TS, Yang Y, Huff CD, Yun H, Qin G, Witherspoon DJ et al (2010) Genetic evidence for high-altitude adaptation in Tibet. Science 329:72–75PubMedView ArticleGoogle Scholar
- Bigham A, Bauchet M, Pinto D, Mao X, Akey JM, Mei R et al (2010) Identifying signatures of natural selection in Tibetan and Andean populations using dense genome scan data. PLoS Genet 6:e1001116PubMed CentralPubMedView ArticleGoogle Scholar
- Xu S, Li S, Yang Y, Tan J, Lou H, Jin W et al (2011) A genome-wide search for signals of high-altitude adaptation in Tibetans. Mol Biol Evol 28:1003–1011PubMedView ArticleGoogle Scholar
- Mojiri A, Nakhaii-Nejad M, Phan WL, Kulak S, Radziwon-Balicka A, Jurasz P et al (2013) Hypoxia results in upregulation and de novo activation of von Willebrand factor expression in lung endothelial cells. Arterioscler Thromb Vasc Biol 33:1329–1338PubMedView ArticleGoogle Scholar
- Farrell AJ, Williams RB, Stevens CR, Lawrie AS, Cox NL, Blake DR (1992) Exercise induced release of von Willebrand factor: evidence for hypoxic reperfusion microvascular injury in rheumatoid arthritis. Ann Rheum Dis 51:1117–1122PubMed CentralPubMedView ArticleGoogle Scholar
- Pinsky DJ, Naka Y, Liao H, Oz MC, Wagner DD, Mayadas TN et al (1996) Hypoxia-induced exocytosis of endothelial cell Weibel-Palade bodies. A mechanism for rapid neutrophil recruitment after cardiac preservation. J Clin Invest 97:493–500PubMed CentralPubMedView ArticleGoogle Scholar
- Caramuru LH, Soares Rde P, Maeda NY, Lopes AA (2003) Hypoxia and altered platelet behavior influence von Willebrand factor multimeric composition in secondary pulmonary hypertension. Clin Appl Thromb Hemost 9:251–258PubMedView ArticleGoogle Scholar
- Tyagi T, Ahmad S, Gupta N, Sahu A, Ahmad Y, Nair V et al (2014) Altered expression of platelet proteins and calpain activity mediate hypoxia-induced prothrombotic phenotype. Blood 123:1250–1260PubMedView ArticleGoogle Scholar
- Bauer EM, Zheng H, Comhair S, Erzurum S, Billiar TR, Bauer PM (2011) Complement C3 deficiency attenuates chronic hypoxia-induced pulmonary hypertension in mice. PLoS One 6:e28578PubMed CentralPubMedView ArticleGoogle Scholar
- McDonald TP, Cottrell M, Clift R (1978) Effects of short-term hypoxia on platelet counts of mice. Blood 51:165–175PubMedGoogle Scholar